Catherine Arnaudeau-Bégard

Dr. Catherine Arnaudeau-Bégard is a highly accomplished professional with a solid background in genetics and toxicological genetics.

She pursued her academic endeavors with a Ph.D. in Toxicological Genetics from Stockholm University, where she honed her expertise.

Prior to that, she excelled in her studies with a Magistère in Genetics from Université Denis Diderot (Paris VII) and a Master of Sciences in Genetics, graduating at the top of her class and with distinction.

Dr. Arnaudeau-Bégard has held various prominent positions in prestigious organizations, showcasing her leadership and expertise.

Currently, she is the Owner and Founder of CADENCE PATRIMOINE, demonstrating her entrepreneurial spirit and business acumen.

She has a rich history with UCB, where she held roles such as Head of Medical Europe, Senior Director in Information Intelligence & Integrity, Director / Senior Director in Medical Affairs Center of Expertise, Director in Global Head Scientific Public Disclosure, and Associate Director in Global Head of Publications.

Her experience also extends to GlaxoSmithKline Biologicals, where she worked as a Global Lead Publications Manager, highlighting her versatility in the pharmaceutical industry.

Dr. Arnaudeau-Bégard's scientific journey includes pivotal roles at esteemed institutions like CEA, CNRS, and Stockholm University, where she contributed significantly as a Senior Scientist, Project Leader, Postdoctoral Research Scientist, and Junior Research Scientist respectively.

Her diverse professional background underscores her proficiency in scientific research, medical affairs, publications, and information intelligence, making her a well-rounded expert in her field.

Dr. Catherine Arnaudeau-Bégard's career trajectory exemplifies her passion for genetics, leadership acumen, and strategic thinking, positioning her as a notable figure in the scientific and pharmaceutical spheres.